Familial hyperparathyroidism due to a germline mutation of the CDC73 gene: Implications for management and age-appropriate testing of relatives at risk

Endocrine Practice

Volumn 17, Issue 4, 2011, Pages 602-609

  Pichardo Lowden, Ariana R ^a   Manni, Andrea ^a   Saunders, Brian D ^a   Baker, Maria J ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GENOMIC DNA; MESSENGER RNA; PARATHYROID HORMONE;

ADULT; CDC73 GENE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EXON; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GERM LINE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM JAW TUMOR SYNDROME; JAW TUMOR; LABORATORY TEST; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PEDIGREE; PRIMARY HYPERPARATHYROIDISM; RELATIVE; REVIEW;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM; MALE; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84860409929     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10337.RA     Document Type: Review

References (34)

1. Iacobone M, Masi G, Barzon L, et al. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg. 2009;394:817-825.
2. Marx SJ, Simonds WF, Agarwal SK, et al. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res. 2002;17(suppl 2):N37-N43. (Pubitemid 35222311)
3. Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore). 2002; 81:1-26. (Pubitemid 34081284)
4. Warner JV, Nyholt DR, Busfeld F, et al. Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. J Med Genet. 2006;43:e12.
5. Silveira LG, Dias EP, Marinho BC, Gomez RS, De Marco L, Sarquis MS. HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach? Arq Bras Endocrinol Metabol. 2008; 52:1211-1220.
6. Evans DB, Rich TA, Cote GJ. Surgical management of familial hyperparathyroidism. Ann Surg Oncol. 2007;14: 1525-1527. (Pubitemid 46790991)
7. Villablanca A, Calender A, Forsberg L, et al. Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet. 2004;41:e32.
8. Carpten JD, Robbins CM, Villablanca A, et al. HRPT2, encoding parafbromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676-680. (Pubitemid 35435184)
9. Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat. 2010;31:295-307.
10. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, et al. The parafbromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol. 2005;25:612-620. (Pubitemid 40096583)
11. Newey PJ, Bowl MR, Thakker RV. Parafbromin-func-tional insights. J Intern Med. 2009;266:84-98.
12. Jackson CE, Norum RA, Boyd SB, et al. Hereditary hyperparathyroidism and multiple ossifying jaw fbromas: a clinically and genetically distinct syndrome [with discussion]. Surgery. 1990;108:1006-1013.
13. Rich TA, Cabanillas ME, Martin JW, Perrier ND, Waguespack SG (U.S. National Library of Medicine, National Institutes of Health). GeneReviews. CDC73-Related Disorders. December 31, 2008. Bookshelf ID: NBK3789. PMID: 20301744. http://www.ncbi.nlm.nih.gov/books/NBK3789/. Accessed for verifcation April 12, 2011.
14. Bradley KJ, Hobbs MR, Buley ID, et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2005;257:18-26. (Pubitemid 40129123)
15. Cavaco BM, Guerra L, Bradley KJ, et al. Hyperpara-thyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab. 2004;89:1747-1752. (Pubitemid 38507929)
16. Inoue H, Miki H, Oshimo K, et al. Familial hyperpara-thyroidism associated with jaw fbroma: case report and literature review [with discussion]. Clin Endocrinol (Oxf). 1995;43:225-230.
17. Pimenta FJ, Gontijo Silveira LF, Tavares GC, et al. HRPT2 gene alterations in ossifying fbroma of the jaws. Oral Oncol. 2006;42:735-739. (Pubitemid 44094240)
18. Stälberg P, Carling T. Familial parathyroid tumors: diagnosis and management. World J Surg. 2009;33:2234-2243.
19. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med. 2005;257:27-37. (Pubitemid 40129124)
20. Guarnieri V, Scillitani A, Muscarella LA, et al. Diagnosis of parathyroid tumors in familial isolated hyperparathy-roidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab. 2006;91:2827-2832. (Pubitemid 44271719)
21. Warnakulasuriya S, Markwell BD, Williams DM. Familial hyperparathyroidism associated with cementify-ing fbromas of the jaws in two siblings. Oral Surg Oral Med Oral Pathol. 1985;59:269-274. (Pubitemid 15045796)
22. Szabó J, Heath B, Hill VM, et al. Hereditary hyperpara-thyroidism- jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet. 1995;56:944-950.
23. Iacobone M, Barzon L, Porzionato A, et al. Parafbromin expression, single-gland involvement, and limited parathy-roidectomy in familial isolated hyperparathyroidism [with discussion]. Surgery. 2007;142:984-991. (Pubitemid 350184117)
24. Shattuck TM, Välimäki S, Obara T, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722-1729. (Pubitemid 37315009)
25. Cetani F, Pardi E, Borsari S, et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab. 2004;89:5583-5591. (Pubitemid 39518444)
26. Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafbromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 2006;30:1140-1149. (Pubitemid 44299347)
27. Juhlin C, Larsson C, Yakoleva T, et al. Loss of paraf-bromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer. 2006;13:509-523. (Pubitemid 43886673)
28. DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol. 2005;12:53-61.
29. Sarquis MS, Silveira LG, Pimenta FJ, et al. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery. 2008;143:630-640.
30. Barry MK, van Heerden JA, Grant CS, Thompson GB, Khosla S. Is familial hyperparathyroidism a unique disease? Surgery. 1997;122:1028-1033. (Pubitemid 28016669)
31. Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH. Familial hyperparathyroidism without multiple endocrine neoplasia [with discussion]. World J Surg. 1997;21:22-29. (Pubitemid 27026712)
32. Lal A, Bianco J, Chen H. Radioguided parathyroidectomy in patients with familial hyperparathyroidism. Ann Surg Oncol. 2007;14:739-743 (Pubitemid 46175320)
33. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psycho-social implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233-1241.
34. Laxova R. Testing for cancer susceptibility genes in children. Adv Pediatr. 1999;46:1-40.